Since the FDA began publishing Complete Response Letters (CRLs), we’ve been analyzing them to uncover where drug applications fall short and how to avoid the same pitfalls. The result is a growing library of white papers translating real regulatory feedback into actionable insights. 

So far, we have launched four white papers, each addressing critical areas of regulatory scrutiny: Extractables and Leachables (E&L), Container Closure Integrity Testing (CCIT), Method Validation and Cell-based Assays (CBBA).

Fill out the form below to unlock the series and access practical recommendations grounded in real FDA feedback.